Skip to main content

Table 2 Cox Proportional Hazards Models of survival as a function of the molecular phenotypes (SOX2+/CDX2- vs SOX2-/CDX2+) for each clinicopathological parameter

From: Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome

Parameter Hazard ratio (95% CI)    
  Unadjusted P Adjusteda P
Overall 1.95 (1.15-3.31) 0.01 1.90 (1.10-3.28) 0.02
Laurén classification     
  Intestinal-type 3.18 (1.33-7.58) 0.009 2.93 (1.21-7.10) 0.02
  Diffuse-type 1.35 (0.35-5.17) 0.7   
  Unclassified 1.34 (0.60-3.02) 0.5   
Ming classification     
  Expanding 4.84 (1.64-14.29) 0.004 4.53 (1.29-15.85) 0.02
  Infiltrative 1.13 (0.60-2.13) 0.7   
Vascular invasion     
  Negative 3.84 (1.30-11.35) 0.02 3.82 (1.29-11.40) 0.02
  Positive 1.10 (0.60-2.02) 0.8   
N stage     
  N0 2.96 (0.82-10.65) 0.1 3.98 (0.72-21.83) 0.1
  N+ 1.29 (0.72-2.30) 0.4   
  1. Abbreviation: CI confidence interval.
  2. a Adjusted for age and gender (Multivariate analysis using the Cox regression model).
\